Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
Jim Cramer urges discipline on GE Vernova as Wall Street analysts get more bullish
Wall Street analysts have increasingly jumped on the GE Vernova bandwagon during a volatile week for the stock…
Cramer slams Amazon for considering a circular AI deal reminiscent of the dotcom bubble
Jim Cramer implores Amazon not to engage in “sham-like” circular AI deals that remind him of the kind…
Amazon announces new AI chips, closer Nvidia ties — but it’s cloud capacity that matters most
Amazon Web Services’ two-track approach to artificial intelligence came into better focus Tuesday as the world’s biggest cloud…
With the AI trade under pressure, Cramer looks at stocks outside of tech to buy
Jim Cramer and Jeff Marks held the CNBC Investing Club’s November Monthly Meeting on Thursday. Let’s start with…
Meta faces a new threat from OpenAI’s new viral Sora 2 video app
Meta is facing new pressure from OpenAI, the juggernaut behind ChatGPT, which is now making waves in short-form…
How a $100 billion pledge helped Wall Street forget about Apple’s AI problems — for now
Nothing like $100 billion to make everyone forget about the AI elephant in the room for Apple. CEO…
The AI gold rush is here, but adoption data shows that its just getting started
The adoption of artificial intelligence tools is increasing at a rapid pace but remains far from ubiquity, providing…
Our bottom 5 stocks for the first half of 2025 — why we still own them
Tuesday marks the first day of trading for the second half of 2025. It was a rocky six…